Clinical Trials Logo

Filter by:
NCT ID: NCT05770674 Recruiting - Clinical trials for Coronary Artery Disease

Comparison of 1 Month vs. 12 Months DAPT in Patients Undergoing PCI With Genoss® DES

GENOSS-DAPT
Start date: April 1, 2022
Phase: N/A
Study type: Interventional

This study is a prospective, open-label, multicenter, randomized clinical trial to evaluate the efficacy of 1 month dual antiplatelet therapy (DAPT) with aspirin plus clopidogrel followed by clopidogrel monotherapy, compared with 12 months DAPT with aspirin plus clopidogrel in patients undergoing percutaneous coronary intervention with Genoss® drug eluting stents.

NCT ID: NCT05772858 Recruiting - Clinical trials for Traditional Face to Face Training

Family Therapy Training and Implementation Platform (FTTIP): An Innovative Web-based Tool for Long-term Practice Improvement

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare whether mental health therapists trained by a Family Therapy Training and Implementation Platform (FTTIP) or those trained in traditional face-to-face training differ on learning key family therapy domains, including competencies, agency readiness, and client outcomes. The main questions it aims to answer are: - Will 75 FTTIP mental health therapists show improvement in all core family therapy competencies that are not inferior to 75 providers receiving traditional in person family therapy training? - Will 150 families (child, parent, dyad) receiving CIFFTA family therapy show adequate retention in treatment therapeutic alliance and significant pre-post treatment improvements on family environment and presenting problems? - Will 15 agency leaders receiving FTTIP agency readiness consultations show more pre and post change in agency readiness and knowledge than 15 leaders receiving agency engagement as usual? Participants will participate in: - Complete pre and post surveys - 20 hours of training in an evidenced based family therapy treatment - 24 weeks of biweekly coaching to implement the treatment - 24 weeks of implementation of the treatment with one family - Agency leaders will complete 2 weeks of organizational readiness engagement Researchers will compare the Family Therapy Training and Implementation Platform (FTTIP) and traditional face-to-face training to see if FTTIP is not inferior to traditional training in key domains, including competencies, agency readiness, and client outcomes in mental health therapists.

NCT ID: NCT05784116 Recruiting - Clinical trials for Depression, Postpartum

Immune/Inflammatory Biomarkers in Postpartum Depression

PPDINFLAME
Start date: April 1, 2022
Phase:
Study type: Observational

This will be a very straightforward study assessing changes of immune/inflammatory peripheral biomarkers before/after delivery with postpartum mood and the psychopathological features of postpartum depression (PPD), and with MRI measures of functional and structural brain integrity. Multimodal assessment of peripheral cytokines, PBMC gene expression, FACS immunophenotyping, and IDO activation, will be validated with (a) clinical data about the presentation of PPD, (b) self- and observer ratings of psychopatology, (c) results coming from neuropsychological assessment of cognitive functions, and (d) multimodal brain imaging outcomes (WM integrity, functional connectivity, GM volumes). It is expected that worsening or stabilization of mood, and the diagnosis of PPD, will be paralleled by worsening or stabilization of these measures, thus providing new markers to estimate the susceptibility to the disorder, to identify targets for treatment, and to predict and monitor treatment efficacy.

NCT ID: NCT05798975 Recruiting - Hypertension Clinical Trials

Analysis of Heart Rate Variability After a Physical Exercise Session

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

Systemic arterial hypertension (SAH) is a multifactorial clinical condition, characterized by sustained elevation of blood pressure levels, contributing to 50% of deaths from cardiovascular disease. The Autonomic Nervous System (ANS) plays a fundamental role in the regulation of Blood Pressure (BP) and is closely associated with Heart Rate (HR). HR changes are called Heart Rate Variability (HRV). In individuals with SAH, HRV indices are reduced compared to normotensive individuals, showing changes in autonomic modulation, thus increasing the risk for cardiovascular events. The objective of this study will be to analyze the Heart Rate Variability in individuals with controlled SAH after a session of aerobic (EA) or resistance (RE) physical exercise.

NCT ID: NCT05802875 Recruiting - Healthy Clinical Trials

Building Resilience During the COVID-19 Pandemic: a Randomized Controlled Trial

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

This clinical trial is to test the efficacy of a Resilience Training (RASMUS) compared to an active control condition (Progressive Muscle Relaxation, PMR) on resilience, psychological distress, and other clinical variables in a group of people out of the general population with clinically relevant psychological symptoms in the context of the COVID-19 pandemic. In addition, this randomized, controlled, parallel-group study will test the efficacy of RASMUS and PMR in relation to brain structure, function, and metabolite levels. In summary, the main study examines the efficacy of two potentially helpful interventions to improve mental health, whereas the imaging sub-study investigates the potential effects of these interventions on brain volumetry and cortical thickness, on metabolite levels in stress-related brain regions, on brain responses, as well as on functional brain connectivity and communication.

NCT ID: NCT05804916 Recruiting - Breast Cancer Clinical Trials

Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer

Start date: April 1, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This study is a single-center,blinded, efficacious, phase III randomized clinical trial initiated by investigators. The primary objective is to investigate the use of Surface Guided Radiation Therapy (SGRT) in combination with Deep Inspiration Breath Hold (DIBH) technique for left breast cancer treatment, compared to traditional laser alignment with free breathing treatment. This approach offers superior positioning accuracy and improved heart protection without any increase in radiation or adverse reactions.

NCT ID: NCT05815914 Recruiting - Malnutrition Clinical Trials

Nutritional Support and Telemedicine

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

The aim of this clinical trial is to assess the implementation of an APP to track the nutritional status and diet habits of "chronic complex patients"(CCP) in order to improve their nutritional status and evaluate the level of adherence to dietetic counseling.

NCT ID: NCT05823779 Recruiting - HIV Disease Clinical Trials

A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects

HSVHIV
Start date: April 1, 2022
Phase:
Study type: Observational

This study is an observational, cohort, prospective study looking at the frequency of Herpes Simplex Virus (HSV) 1 and or 2 outbreaks in HIV positive patients who's HIV virus is controlled on highly active anti-retroviral therapy. We will be enrolling fifty (50) patients.

NCT ID: NCT05824247 Recruiting - Ovarian Cancer Clinical Trials

A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer

Start date: April 1, 2022
Phase:
Study type: Observational

A study to discuss the advantage of Fapi PET- CT in the initial diagnosis staging and lesion determination of ovarian cancer,whether it can be a evaluation strategy as an R0 evaluation tool or a prediction tool of chemotherapy response and evaluation of prognosis.

NCT ID: NCT05835336 Recruiting - ADHD Clinical Trials

A Novel, Non-pharmacological, Intervention for the Management of ADHD in Adolescents

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

This is a 2-month study in which eligible ADHD adolescents will be provided with personalized VIZO Glasses